State of Alaska Department of Revenue Buys New Stake in Astrana Health, Inc. (NASDAQ:ASTH)

State of Alaska Department of Revenue bought a new position in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 23,702 shares of the company's stock, valued at approximately $1,373,000.

Other hedge funds have also recently modified their holdings of the company. NorthCrest Asset Manangement LLC purchased a new position in Astrana Health during the third quarter worth approximately $26,704,000. Louisiana State Employees Retirement System acquired a new position in Astrana Health during the 3rd quarter worth $1,165,000. Guidance Capital Inc. acquired a new position in Astrana Health during the 3rd quarter worth $724,000. SG Americas Securities LLC acquired a new position in shares of Astrana Health during the 3rd quarter worth about $680,000. Finally, Handelsbanken Fonder AB acquired a new position in shares of Astrana Health during the 3rd quarter worth about $492,000. Hedge funds and other institutional investors own 52.77% of the company's stock.

Analyst Ratings Changes

Several research firms have recently weighed in on ASTH. Truist Financial boosted their target price on Astrana Health from $50.00 to $59.00 and gave the company a "buy" rating in a report on Friday, August 9th. KeyCorp started coverage on Astrana Health in a report on Friday, October 11th. They set a "sector weight" rating on the stock. TD Cowen started coverage on Astrana Health in a research note on Monday, October 14th. They set a "buy" rating and a $66.00 price target on the stock. BTIG Research increased their price target on Astrana Health from $60.00 to $70.00 and gave the stock a "buy" rating in a research note on Thursday, October 3rd. Finally, Stifel Nicolaus raised their price objective on Astrana Health from $48.00 to $60.00 and gave the company a "buy" rating in a research report on Thursday, August 1st. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Astrana Health has an average rating of "Buy" and an average target price of $62.00.

Astrana Health Stock Performance

ASTH stock traded down $0.23 during midday trading on Monday, reaching $54.30. The company had a trading volume of 144,294 shares, compared to its average volume of 196,274. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.62. The stock has a 50 day moving average price of $54.93 and a 200 day moving average price of $47.10. Astrana Health, Inc. has a fifty-two week low of $28.86 and a fifty-two week high of $63.20. The firm has a market capitalization of $2.67 billion, a PE ratio of 37.71, a P/E/G ratio of 2.05 and a beta of 1.24.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.39 by $0.01. The company had revenue of $486.30 million for the quarter, compared to analysts' expectations of $440.68 million. Astrana Health had a return on equity of 10.71% and a net margin of 4.30%. The business's revenue for the quarter was up 39.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.28 earnings per share. Analysts anticipate that Astrana Health, Inc. will post 1.31 earnings per share for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.